AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Metbond 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Medilife Healthcare

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Metbond 50/500 Tablet

Diabetam 50/500 tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes, mitigating the risk of severe complications like nephropathy and vision impairment. This dual-action therapy may also lower the likelihood of cardiovascular events. Diabetam 50/500 may be used as monotherapy or in conjunction with other antidiabetic agents, achieving optimal results when paired with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and current medications. Ingesting the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Concurrent use with insulin or sulfonylureas increases the risk of hypoglycemia; understanding its symptoms and management is essential. This medication isn't universally appropriate. Inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption before initiating treatment. Pregnant or lactating individuals require medical consultation. Drug interactions are possible; disclose all medications to ensure treatment safety. Alcohol should be limited due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout the treatment course.

Primary Ingredients of Metbond 50/500 Tablet

The provided text is "undefined," so no rephrasing is possible.

Uses of Metbond 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Metbond 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metbond 50/500 Tablet should be administered with a meal.

Common Side effects of Metbond 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Metbond 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metbond 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Metbond 50/500 Tablet works:

Combiplus 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and heightens insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Metbond 50/500 Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metbond 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Metbond 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metbond 50/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Metbond 50/500 Tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Metbond 50/500 Tablets due to potential safety risks. Medical advice is recommended.

What if you forget to take Metbond 50/500 Tablet :

Should you forget a Metbond 50/500 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Metbond 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Metbond 50/500 Tablet

Metbond 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Metbond 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Metbond 50/500 Tablet may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Metbond 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Metbond 50/500 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medicine and keep it out of reach of children, pets, and others.
Metformin (such as in Metbond 50/500 tablets) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large quantities of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Metbond 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Metbond 50/500 Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Metbond 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol with Metbond 50/500 tablets is unsafe and may heighten the risk of lactic acidosis.
Metformin (like in Metbond 50/500 Tablets) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms after taking Sitagliptin + Metformin, discontinue use and seek immediate medical attention.
Prolonged Metbond 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metbond 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Metbond 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Metbond 50/500 Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Metbond 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Metformin (like in Metbond 50/500 Tablets) can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the bloodstream (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Metbond 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including impaired balance). To mitigate these risks, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Metbond 50/500 Tablet
125
MRP 145
13% off